Steven T. Pals focuses on Cancer research, Immunology, Cell biology, Cell adhesion and Lymphocyte homing receptor. His Cancer research study integrates concerns from other disciplines, such as Wnt signaling pathway, Carcinogenesis, Receptor tyrosine kinase, Colorectal cancer and Bruton's tyrosine kinase. His biological study spans a wide range of topics, including T cell, Naive B cell and Programmed cell death.
His Programmed cell death study incorporates themes from Annexin, Annexin A5 affinity assay and Annexin A2. In his study, which falls under the umbrella issue of Cell adhesion, Cell–cell interaction is strongly linked to Cell adhesion molecule. His studies deal with areas such as T lymphocyte, Neural cell adhesion molecule, Intercellular adhesion molecule and Lymphoma as well as Lymphocyte homing receptor.
Immunology, Cancer research, Pathology, Molecular biology and Cell biology are his primary areas of study. His Immunology research includes elements of Receptor and Cell adhesion. The study incorporates disciplines such as CD44, Receptor tyrosine kinase, Signal transduction, Lymphoma and Colorectal cancer in addition to Cancer research.
In his work, Wnt signaling pathway is strongly intertwined with Carcinogenesis, which is a subfield of Colorectal cancer. His Molecular biology research incorporates elements of CD40, Antigen-presenting cell and Antibody, Germinal center, B cell. His Cell biology research integrates issues from T cell, Biochemistry, Neural cell adhesion molecule and Programmed cell death.
His primary scientific interests are in Cancer research, Immunology, Internal medicine, Lymphoma and MEDLINE. His Cancer research study also includes
The various areas that Steven T. Pals examines in his Internal medicine study include Gastroenterology, CD44 and Oncology. Pathology covers he research in Lymphoma. His research investigates the connection between Inflammation and topics such as T cell that intersect with issues in Apoptosis.
His primary areas of study are Immunology, Ibrutinib, Cancer research, Bruton's tyrosine kinase and Biopsy. His research in Immunology intersects with topics in Phenotype and Cell. He combines subjects such as Immunohistochemistry, Lymphoma, Rituximab, Pathology and Chemotherapy with his study of Ibrutinib.
His research integrates issues of Chronic lymphocytic leukemia and FOXP1 in his study of Cancer research. His Bruton's tyrosine kinase study combines topics in areas such as Idelalisib and Cell adhesion. His Haematopoiesis research is multidisciplinary, relying on both Heparan sulfate and Molecular biology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis.
G. Koopman;C. P. M. Reutelingsperger;G. A. M. Kuijten;R. M. J. Keehnen.
Expression of CD44 Variant Proteins in Human Colorectal Cancer Is Related to Tumor Progression
V. J. M. Wielenga;K.-H. Heider;G. J. A. Offerhaus;G. R. Adolf.
Cancer Research (1993)
Expression of CD44 in Apc and Tcf Mutant Mice Implies Regulation by the WNT Pathway
Vera J.M. Wielenga;Ron Smits;Vladimir Korinek;Lia Smit.
American Journal of Pathology (1999)
The clinically active BTK inhibitor PCI-32765 targets B-cell receptor- and chemokine-controlled adhesion and migration in chronic lymphocytic leukemia
Martin F. M. de Rooij;Annemieke Kuil;Christian R. Geest;Eric Eldering.
Graft-versus-host reactions: clues to the etiopathology of a spectrum of immunological diseases
Ernst Gleichmann;Steven T. Pals;Anton G. Rolink;Anton G. Rolink;Thadädus Radaszkiewicz;Thadädus Radaszkiewicz.
Immunology Today (1984)
A human homologue of the rat metastasis-associated variant of CD44 is expressed in colorectal carcinomas and adenomatous polyps.
K H Heider;M Hofmann;E Hors;F van den Berg.
Journal of Cell Biology (1993)
Adhesion of human B cells to follicular dendritic cells involves both the lymphocyte function-associated antigen 1/intercellular adhesion molecule 1 and very late antigen 4/vascular cell adhesion molecule 1 pathways.
G. Koopman;H. K. Parmentier;H.-J. Schuurman;W. Newman.
Journal of Experimental Medicine (1991)
The AC133 Epitope, but not the CD133 Protein, Is Lost upon Cancer Stem Cell Differentiation
Kristel Kemper;Martin R. Sprick;Martijn de Bree;Alessandro Scopelliti.
Cancer Research (2010)
Activated human lymphocytes and aggressive non-Hodgkin's lymphomas express a homologue of the rat metastasis-associated variant of CD44
G Koopman;K H Heider;E Horst;G R Adolf.
Journal of Experimental Medicine (1993)
CD44 splice variants: metastases meet lymphocytes
Peter Herrlich;Margot Zöller;Steven T. Pals;Helmut Ponta.
Immunology Today (1993)
Profile was last updated on December 6th, 2021.
Research.com Ranking is based on data retrieved from the Microsoft Academic Graph (MAG).
The ranking d-index is inferred from publications deemed to belong to the considered discipline.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: